Eli Lilly and Company
S&P 500Last update: Mar 25, 2026 at 04:53
About Eli Lilly and Company
Eli Lilly and Company is a leading pharmaceutical company engaged in the discovery, development, manufacture, and sale of human pharmaceutical products. It focuses on innovative medicines addressing critical health needs in areas such as diabetes, oncology, immunology, neuroscience, obesity, cardiovascular diseases, cancer, and other therapeutic categories including bone muscle joint disorders, endocrine conditions, dermatology, autoimmune diseases, sleep apnea, migraine, and Alzheimer's disease. The company offers treatments like insulins, GLP-1 therapies for diabetes and obesity, oncology drugs, immunologic agents, and neuroscience products. Eli Lilly and Company supports access initiatives through partnerships for technology transfer and API supply to manufacturers in low- and middle-income countries, enhancing availability of insulins and other therapies in regions like Africa and Bangladesh. It maintains a robust research and development pipeline targeting non-communicable diseases, with late-stage projects in diabetes, cardiovascular, and oncology areas. Founded in 1876 and headquartered in Indianapolis, Indiana, Eli Lilly and Company plays a significant role in the global health technology sector by delivering therapies that improve patient outcomes across diverse medical fields.
Dividend Overview
Dividend Yield
0.63%
Annual Dividend
$6.23
Frequency
Quarterly
Payout Ratio
26.14%
FCF Payout Ratio
90.27%
Stock Price
$903.02
52-Week Range
$623.78 – $1133.95
Dividend Health Score
LLY's dividend appears very safe. Strengths include a 26.1% earnings payout ratio & 22.8% cfo payout ratio. Areas of concern: 90.3% fcf payout ratio. The dividend has been growing at a 15.18% 5-year CAGR.
Based on 14 of 15 metrics
Payout & Coverage
SafeBalance Sheet
CautionProfitability
Very SafeDividend Track Record
Very SafeDividend History (2016–2025)
LLY annual dividend per share and yield history
Earnings & Profitability
LLY earnings per share and net profit margin
Key Dates
Next Ex-Dividend Date
February 13, 2026
Next Payment Date
March 10, 2026
Dividend Growth
3-Year Dividend CAGR
15.24%
5-Year Dividend CAGR
15.18%
10-Year Dividend CAGR
11.61%
3-Year Total Growth
53.06%
5-Year Total Growth
102.70%
10-Year Total Growth
200.00%
Income Calculator
Similar Dividend Stocks
Frequently Asked Questions
What is LLY's current dividend yield?
When is LLY's next dividend payment date?
How much does LLY pay in dividends per year?
Has LLY been increasing its dividend?
Is LLY's dividend safe?
How is LLY's Dividend Health Score calculated?
Want to understand how we rate dividend safety? Read our full methodology
Track LLY Dividends with OnlyDividends
What will LLY actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.
This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.
Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Health Score, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.
Market data provided by Twelve Data.